SciBase receives approval by FDA for extended labelling in the US
PR Newswire —
STOCKHOLM, March 2, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that it has received approval by FDA for its supplement to extend the labelling to include other healthcare...